DUKE Robotics Corp. (DUKR) grants CFO 10,000 stock options

Rhea-AI Filing Summary

Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.

DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zakai Shlomo

Role CHIEF FINANCIAL OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	10,000	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock — 10,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zakai Shlomo

(Last) (First) (Middle)

C/O DUKE ROBOTICS CORP.

10 HARIMON STREET

(Street)

MEVO CARMEL SCIENCE & IND PARK L3 2069203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUKE Robotics Corp. [ DUKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$7.88	03/10/2026		A		10,000(1)		(1)	03/10/2032	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on March 10, 2027.

	/s/ Shlomo Zakai	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DUKE Robotics (DUKR) report for Zakai Shlomo?

DUKE Robotics reported that CFO Zakai Shlomo received an option grant for 10,000 shares of common stock. The grant is a compensation-related award, not an open-market purchase or sale of existing shares.

What are the key terms of Zakai Shlomo’s new stock options at DUKE Robotics (DUKR)?

The new option covers 10,000 shares of DUKE Robotics common stock at an exercise price of $7.88 per share. The option represents a right to buy stock in the future at this fixed price.

When do the DUKE Robotics (DUKR) options granted to Zakai Shlomo start vesting?

The option granted to Zakai Shlomo vests in three equal annual installments beginning on March 10, 2027. This means one-third of the grant becomes exercisable each year starting on that date.

When do Zakai Shlomo’s DUKE Robotics (DUKR) stock options expire?

The option to purchase DUKE Robotics common stock expires on March 10, 2032. After this expiration date, any unexercised portion of the 10,000-share option will no longer be exercisable.

Is Zakai Shlomo’s DUKE Robotics (DUKR) Form 4 transaction a market buy or sell?

The Form 4 shows an option grant, coded as an acquisition (A), rather than a market buy or sell. It is a compensation award providing a future right to purchase shares at a set price.